Company · KOD
Kodiak Sciences Inc
Name as listed on its exchange; filed with the SEC as Kodiak Sciences Inc.
Nasdaq's symbol directory lists KOD on Nasdaq as “Kodiak Sciences Inc - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 4 occasions ($181.3M); insiders sold on 1 occasion ($2.7M); 1 planned-sale notice; 2 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- BAKER BROS. ADVISORS LP bought $181.3M
- John A. Borgeson, Chief Financial Officer sold $2.7M
Every trade (5)
- BUYBAKER BROS. ADVISORS LP bought $8.5M
- BUYBAKER BROS. ADVISORS LP bought $15.8M
- SELLJohn A. Borgeson, Chief Financial Officer sold $2.7M
- BUYBAKER BROS. ADVISORS LP bought $2.9M
- BUYBAKER BROS. ADVISORS LP bought $154.1M
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- JOHN BORGESON $2.8M
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Baker Bros. Advisors LP 35%
- T. Rowe Price Associates, Inc. 5.2%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Other events Sep 28, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.